We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
-19.74%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$261M
AUM Growth
+$26.1M
(+11%)
Cap. Flow
+$82.8M
Cap. Flow
% of AUM
31.8%
Top 10 Holdings %
Top 10 Hldgs %
37.23%
Holding
89
New
29
Increased
20
Reduced
14
Closed
14
Top Buys
| 1 |
Cencora
COR
|
+$11.5M |
| 2 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$11M |
| 3 |
CVS Health
CVS
|
+$10.8M |
| 4 |
Medtronic
MDT
|
+$8.96M |
| 5 |
Cardinal Health
CAH
|
+$7.66M |
Top Sells
| 1 |
GSK
GSK
|
+$14.6M |
| 2 |
AET
Aetna Inc
AET
|
+$12.3M |
| 3 |
Kura Oncology
KURA
|
+$7.72M |
| 4 |
Biogen
BIIB
|
+$6.82M |
| 5 |
Elevance Health
ELV
|
+$6.8M |
Sector Composition
| 1 | Healthcare | 95.93% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Medtronic
MDT
$102B
| $11.9M | 4.58% |
131,115
+95,919
| +273% | +$8.96M |
|
2
Sanofi
SNY
$103B
| $11.7M | 4.47% |
268,388
+2,000
| +0.8% | +$88.2K |
|
3
Alnylam Pharmaceuticals
ALNY
$37.6B
| $11.3M | 4.33% |
154,637
+50,461
| +48% | +$3.88M |
|
|
4
Cencora
COR
$58.8B
| $9.96M | 3.83% |
+133,934
| New | +$11.5M |
|
5
Cigna
CI
$80.2B
| $9.92M | 3.81% |
52,216
-15,233
| -23% | -$3.18M |
|
|
6
CVS Health
CVS
$135B
| $9.49M | 3.64% |
+144,777
| New | +$10.8M |
|
|
7
Cardinal Health
CAH
$53.9B
| $9.32M | 3.58% |
209,009
+147,005
| +237% | +$7.66M |
|
8
HCA Healthcare
HCA
$80.7B
| $8.47M | 3.25% |
68,039
-15,783
| -19% | -$2.12M |
|
|
GWPH
9
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $8.2M | 3.15% |
+84,186
| New | +$11M |
|
|
NVO
10
Novo Nordisk
NVO
$217B
| $6.79M | 2.61% |
+294,756
| New | +$6.55M |
|
|
CELG
11
DELISTED
Celgene Corp
CELG
| $6.56M | 2.52% |
+102,390
| New | +$7.56M |
|
|
LITS
12
Lite Strategy Inc
LITS
$33.9M
| $6.27M | 2.41% |
118,692
+3,510
| +3% | +$216K |
|
13
Gilead Sciences
GILD
$161B
| $6.04M | 2.32% |
+96,480
| New | +$6.74M |
|
|
UROV
14
DELISTED
Urovant Sciences Ltd.
UROV
| $5.32M | 2.04% |
807,860
+216,406
| +37% | +$1.97M |
|
15
McKesson
MCK
$94.1B
| $5.14M | 1.97% |
+46,530
| New | +$5.8M |
|
16
Viatris
VTRS
$19B
| $5.13M | 1.97% |
+187,175
| New | +$6.06M |
|
|
PINC
17
DELISTED
Premier
PINC
| $5.02M | 1.93% |
134,412
-10,000
| -7% | -$413K |
|
18
Rigel Pharmaceuticals
RIGL
$762M
| $5.01M | 1.93% |
218,055
+33,705
| +18% | +$951K |
|
19
Molina Healthcare
MOH
$12.6B
| $4.98M | 1.91% |
+42,869
| New | +$5.62M |
|
20
Neurocrine Biosciences
NBIX
$17.3B
| $4.93M | 1.89% |
+69,000
| New | +$6.61M |
|
21
Viking Therapeutics
VKTX
$4.41B
| $4.87M | 1.87% |
637,046
+423,794
| +199% | +$5.07M |
|
22
Bionano Genomics
BNGO
$13.2M
| $4.85M | 1.86% |
2,394
-7
| -0.3% | -$27.9K |
|
|
DRNA
23
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $4.74M | 1.82% |
+443,409
| New | +$5.83M |
|
24
Humana
HUM
$48.8B
| $4.67M | 1.79% |
16,317
-3,737
| -19% | -$1.18M |
|
25
Emergent Biosolutions
EBS
$387M
| $4.37M | 1.68% |
73,793
+31,994
| +77% | +$2.06M |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA